ABOS
Price
$1.37
Change
+$0.01 (+0.74%)
Updated
Sep 3, 04:59 PM (EDT)
Capitalization
82.99M
74 days until earnings call
CALC
Price
$3.24
Change
+$0.14 (+4.52%)
Updated
Sep 3, 04:59 PM (EDT)
Capitalization
44.99M
Interact to see
Advertisement

ABOS vs CALC

Header iconABOS vs CALC Comparison
Open Charts ABOS vs CALCBanner chart's image
Acumen Pharmaceuticals
Price$1.37
Change+$0.01 (+0.74%)
Volume$18.29K
Capitalization82.99M
CalciMedica
Price$3.24
Change+$0.14 (+4.52%)
Volume$500
Capitalization44.99M
ABOS vs CALC Comparison Chart in %
Loading...
ABOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CALC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABOS vs. CALC commentary
Sep 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABOS is a Hold and CALC is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 04, 2025
Stock price -- (ABOS: $1.36 vs. CALC: $3.10)
Brand notoriety: ABOS and CALC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABOS: 30% vs. CALC: 491%
Market capitalization -- ABOS: $82.99M vs. CALC: $44.99M
ABOS [@Biotechnology] is valued at $82.99M. CALC’s [@Biotechnology] market capitalization is $44.99M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.69B to $0. The average market capitalization across the [@Biotechnology] industry is $1.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABOS’s FA Score shows that 0 FA rating(s) are green whileCALC’s FA Score has 1 green FA rating(s).

  • ABOS’s FA Score: 0 green, 5 red.
  • CALC’s FA Score: 1 green, 4 red.
According to our system of comparison, CALC is a better buy in the long-term than ABOS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABOS’s TA Score shows that 2 TA indicator(s) are bullish while CALC’s TA Score has 4 bullish TA indicator(s).

  • ABOS’s TA Score: 2 bullish, 6 bearish.
  • CALC’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, CALC is a better buy in the short-term than ABOS.

Price Growth

ABOS (@Biotechnology) experienced а -6.85% price change this week, while CALC (@Biotechnology) price change was +8.01% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.32%. For the same industry, the average monthly price growth was +16.10%, and the average quarterly price growth was +32.67%.

Reported Earning Dates

ABOS is expected to report earnings on Nov 17, 2025.

Industries' Descriptions

@Biotechnology (+0.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ABOS($83M) has a higher market cap than CALC($45M). CALC YTD gains are higher at: -12.429 vs. ABOS (-20.930). CALC has higher annual earnings (EBITDA): -30.55M vs. ABOS (-132.35M). ABOS has more cash in the bank: 143M vs. CALC (18M). CALC has less debt than ABOS: CALC (8.5M) vs ABOS (30.1M). ABOS (0) and CALC (0) have equivalent revenues.
ABOSCALCABOS / CALC
Capitalization83M45M184%
EBITDA-132.35M-30.55M433%
Gain YTD-20.930-12.429168%
P/E RatioN/A0.30-
Revenue00-
Total Cash143M18M794%
Total Debt30.1M8.5M354%
TECHNICAL ANALYSIS
Technical Analysis
ABOSCALC
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
75%
MACD
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
74%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 17 days ago
78%
Bullish Trend 8 days ago
78%
Declines
ODDS (%)
Bearish Trend 7 days ago
88%
Bearish Trend 6 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
ABOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CALC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CLOV2.690.07
+2.67%
Clover Health Investments Corp
QETA11.19N/A
N/A
Quetta Acquisition Corp
AXP331.18-0.10
-0.03%
American Express Company
WH86.35-0.26
-0.30%
Wyndham Hotels & Resorts
CTRN35.02-0.61
-1.71%
Citi Trends

ABOS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABOS has been loosely correlated with KYTX. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if ABOS jumps, then KYTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABOS
1D Price
Change %
ABOS100%
N/A
KYTX - ABOS
46%
Loosely correlated
-3.23%
CRBU - ABOS
46%
Loosely correlated
+0.53%
GLSI - ABOS
44%
Loosely correlated
-0.17%
BEAM - ABOS
44%
Loosely correlated
-0.31%
CELC - ABOS
43%
Loosely correlated
+4.59%
More

CALC and

Correlation & Price change

A.I.dvisor tells us that CALC and PRRUF have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CALC and PRRUF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CALC
1D Price
Change %
CALC100%
+14.81%
PRRUF - CALC
26%
Poorly correlated
N/A
CNSP - CALC
25%
Poorly correlated
+0.81%
ABOS - CALC
23%
Poorly correlated
N/A
PCSA - CALC
22%
Poorly correlated
-0.48%
ORMP - CALC
22%
Poorly correlated
-2.27%
More